Reintervención precoz de la hipertensión tromboembólica crónica debida a sarcoma arterial pulmonar
Cirugía Cardiovascular, 2018 Resumen: El tratamiento de elección en la hipertensión pulmonar tromboembólica crónica es la tromboendarterectomía pulmonar quirúrgica (indicación clase I).
Carlos Domínguez-Massa +5 more
doaj +1 more source
Right ventricular outflow tract velocity time integral-to-pulmonary artery systolic pressure ratio: a non-invasive metric of pulmonary arterial compliance differs across the spectrum of pulmonary hypertension. [PDF]
, 2019 Pulmonary arterial compliance (PAC), invasively assessed by the ratio of stroke volume to pulmonary arterial (PA) pulse pressure, is a sensitive marker of right ventricular (RV)-PA coupling that differs across the spectrum of pulmonary hypertension (PH ...
Bhattacharya, Priyanka T. +15 more
core +2 more sources
Pulmonary artery sarcoma diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration [PDF]
, 2014 published_or_final_versio
Alex KC Leung +8 more
core +1 more source
Cardiac interventions in patients with achondroplasia: a systematic review. [PDF]
, 2020 Patients with achondroplasia and other causes of dwarfism suffer from increased rates of cardiovascular disease relative to the remainder of the population.
Choi, Jae Hwan +6 more
core +1 more source
Pulmonary arterial hypertension: a new era in management [PDF]
, 2003 The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.Pulmonary arterial hypertension (PAH) is a heterogeneous condition with a wide range of ...
Cleland, L. +4 more
core +1 more source
Cirugía Cardiovascular, 2020 Resumen: Introducción y objetivos: La hipertensión pulmonar tromboembólica crónica es una rara consecuencia de la embolia pulmonar aguda. La cirugía de tromboendarterectomía pulmonar es el tratamiento de elección.
Consuelo A. Gotor-Pérez +12 more
doaj +1 more source
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. [PDF]
, 2013 BACKGROUND: Riociguat, a member of a new class of compounds (soluble guanylate cyclase stimulators), has been shown in previous clinical studies to be beneficial in the treatment of chronic thromboembolic pulmonary hypertension. METHODS: In this phase 3,
CHEST-1 Study Group, +13 more
core +1 more source
Medicina, 2021 Chronic thromboembolic pulmonary hypertension (CTEPH) is a specific type of pulmonary hypertension (PH) and the major component of Group 4 pulmonary hypertension (PH). It is caused by pulmonary vasculature obstruction that leads to a progressive increase
Munish Sharma, Deborah Jo Levine
doaj +1 more source
Left pulmonary artery thrombosis in a neonate with left lung hypoplasia [PDF]
, 2012 Thrombotic events in neonates may origin from fetal life. A 4-day-old newborn infant with a family history of heterozygous type 1 protein C deficiency was diagnosed with left lung hypoplasia and left pulmonary artery thrombosis. Its source was prenatally
Hazekamp, M.G. +4 more
core +4 more sources
Pulmonary thromboendarterectomy in pediatric patients: Report of three cases
The Turkish Journal of Pediatrics, 2018 Chronic thromboembolic pulmonary hypertension (CTEPH), which occurs due to impartial resolution of the pulmonary thrombus, is a rare type of pulmonary hypertension.
Ulaş Kumbasar +4 more
doaj +1 more source